Docoh
Loading...

HSAQ Health Sciences Acquisitions Corp 2

Health Sciences Acquisitions Corporation 2 is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The sponsor of the Company is HSAC 2 Holdings, LLC, an affiliate of RTW Investments, LP. HSAC 2 anticipates targeting companies domiciled in North America or Europe that are developing assets in the biopharmaceutical and medical technology sectors, which aligns with the Company's management team's experience in healthcare investing and drug development.

HSAQ stock data

(
)

Calendar

16 Aug 21
19 Oct 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 3.71M 3.71M 3.71M 3.71M 3.71M 3.71M
Cash burn (monthly) 79.71K 19.93K 32.11K 23.07K 30.78K 19.58K
Cash used (since last report) 291.57K 72.89K 117.43K 84.4K 112.57K 71.6K
Cash remaining 3.42M 3.64M 3.59M 3.63M 3.6M 3.64M
Runway (months of cash) 42.9 182.6 111.9 157.2 116.9 185.9

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
6 Aug 20 HSAC 2 Ordinary Shares Buy Acquire P No No 10 450,000 4.5M 4,360,956
6 Aug 20 HSAC 2 Warrants to purchase Ordinary Shares Ordinary Shares Buy Acquire P No No 1 1,500,000 1.5M 1,500,000
4 Aug 20 Alice Lee Ordinary Shares Buy Acquire P No No 10 10,000 100K 10,000
4 Aug 20 Stephanie A Sirota Ordinary Shares Buy Acquire P Yes No 10 20,000 200K 20,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

80.4% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 51 47 +8.5%
Opened positions 7 7
Closed positions 3 7 -57.1%
Increased positions 12 7 +71.4%
Reduced positions 9 4 +125.0%
13F shares
Current Prev Q Change
Total value 179.15M 186.03M -3.7%
Total shares 16.45M 15.98M +2.9%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
HSAC 2 4.36M $55.86M 0.0%
Davidson Kempner Capital Management 925.21K $9.44M +48.1%
TROW T. Rowe Price 810.14K $8.26M -4.7%
Adage Capital Partners GP, L.L.C. 800K $8.16M 0.0%
BLK Blackrock 797.35K $8.13M -0.3%
Putnam Investments 750K $7.65M 0.0%
Wellington Management 626.37K $6.39M -1.9%
Ra Capital Management 625K $6.38M 0.0%
Amitell Capital Pte 537.27K $5.48M +12.2%
Orbimed Advisors 500K $5.1M 0.0%
Largest transactions
Shares Bought/sold Change
Cormorant Asset Management 240K -560K -70.0%
Davidson Kempner Capital Management 925.21K +300.49K +48.1%
Murchinson 300K +300K NEW
K2 Principal Fund 320.35K +255.44K +393.6%
Governors Lane 250K +250K NEW
Logos Global Management 100K -200K -66.7%
Atw Spac Management 157.16K +157.16K NEW
Sphera Funds Management 0 -100K EXIT
Affinity Asset Advisors 300K +75K +33.3%
Amitell Capital Pte 537.27K +58.38K +12.2%

Financial report summary

?
Management Discussion
  • Our entire activity since inception up to June 30, 2021 was for our formation, preparation for our Initial Public Offering, and, since the closing of our Initial Public Offering, a search for business combination candidates. We will not be generating any operating revenues until the closing and completion of our initial Business Combination.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
Coll. sophomore V bad

Proxies

No filings